Fundraising Fox
노벨티노빌리티
Pangyo, KR · 1 known investors
Find your way into 노벨티노빌리티
Sign up to see every warm intro you have to 노벨티노빌리티
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 노벨티노빌리티 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novelty Nobility develops antibody and protein therapeutics for clinical applications. The company's leadership team brings expertise in immunization, affinity maturation, and biopharmaceutical development across therapeutic areas including ophthalmology.
Founders & leadership
SP
Sang-Gyu ParkFounder & CEO & CTO
CP
Chan-Hee ParkChief Scientific OfficerChan-Hee Park is Chief Scientific Officer at Novelty Nobility, a biopharmaceutical company developing antibody and protein therapeutics. He brings expertise in drug discovery across multiple therapeutic areas including oncology, immunology, and regenerative medicine.
SB
Seungjae BaekChief Medical Officer
GS
Gong SungHead of CMC
TN
Tae-Young NaHead of Disease Research
Investors · 1
Frequently asked questions
- What does 노벨티노빌리티 do?
- Novelty Nobility develops antibody and protein therapeutics for clinical applications. The company's leadership team brings expertise in immunization, affinity maturation, and biopharmaceutical development across therapeutic areas including ophthalmology.
- Who founded 노벨티노빌리티?
- 노벨티노빌리티 was founded by Sang-Gyu Park.
- Who are 노벨티노빌리티's investors?
- 노벨티노빌리티's investors include Solidus Investment.
- Where is 노벨티노빌리티 headquartered?
- 노벨티노빌리티 is headquartered in Pangyo, KR.